Skip to main content
Clinical Trials/NCT05374720
NCT05374720TerminatedNot Applicable

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy

Centre Hospitalier Intercommunal Creteil2 sites in 1 country61 target enrollmentStarted: November 30, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
61
Locations
2
Primary Endpoint
morphological of tubal cilia

Study Overview

Brief Summary

Primary Ciliary Dyskinesia associated with abnormalities of lateralization of organs (with existence of a situs inversus in 50% of cases) and secondary fertility disorders related in humans to abnormalities of mobility of sperm but very little data on the structure and function of tubal cilia in women

Detailed Description

Primary Ciliary Dyskinesia (DCP) is a rare genetic disease (1 in 15,000 individuals at birth), which manifests itself in chronic respiratory infections (bronchopneumopathies and rhinosinusitis type) associated with abnormalities of lateralization of organs (with existence of a situs inversus in 50% of cases) and secondary fertility disorders related in humans to abnormalities of sperm mobility. However, there is very little data in the literature on the structure and function of tubal cilia in women with DCP.

Before considering a study of tubal cilia in patients with DCP, it seems necessary to specify in DCP patients or not DCP, the molecular and morphological composition of tubal cilia and to look for ciliary abnormalities in case of GEU

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with scheduled salpingectomy (Ectopic pregnancy, hysterectomy for prolapsus, adenomyosis or myomectomy)
  • Major patients ( >18 years)

Exclusion Criteria

  • Patient not willing to participate in the study

Arms & Interventions

Salpingectomy for Extra-Uterine Pregnancy

Experimental

patients with salpingectomy for Ectopic Pregnancy

Intervention: salpingectomy (Procedure)

hysterectomies

Sham Comparator

patients with hysterectomy for prolapsus, adenomyosis or myomectomy

Intervention: hysterectomy (Procedure)

Outcomes

Primary Outcomes

morphological of tubal cilia

Time Frame: through study completion, an average of 6 week after surgery

Molecular compositor of tubal ciliar by immunofluorescence study of 14 proteins in vivo and in vitro (tissue cells from patient fallopian tubes)

Molecular difference in tubal cilia between patients with or without GEU salpingectomy

Time Frame: through study completion, an average of 6 week after surgery

compares molecular compositor of tubal ciliar by immunofluorecence study of 14 proteins in vivo and in vitro between patients with or without GEU salpingectomy

molecular tubal cilia

Time Frame: through study completion, an average of 6 week after surgery

Ultrastructure morphology of tubal cell cilia by electron microscopy

functional composition of tubal cell by video microscopy

Time Frame: through study completion, an average of 6 week after surgery

amplitude of moment by video microscopy

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials